Testing effectiveness (Phase 2)Study completedNCT05149898
What this trial is testing
Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE)
Who this might be right for
22Q11.2 Deletion Syndrome
Harmony Biosciences Management, Inc. 20